Presatovir
Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus. It acts as a fusion inhibitor, and has shown promising results in Phase II clinical trials. See also Palivizumab Lumicitabine Ziresovir References Anti–RNA virus drugs Antiviral drugs